Development of Monoclonal Antibody and Diagnostic Test for Middle East Respiratory Syndrome Coronavirus Using Cell-Free Synthesized Nucleocapsid Antigen.
Identifieur interne : 000C70 ( PubMed/Checkpoint ); précédent : 000C69; suivant : 000C71Development of Monoclonal Antibody and Diagnostic Test for Middle East Respiratory Syndrome Coronavirus Using Cell-Free Synthesized Nucleocapsid Antigen.
Auteurs : Yutaro Yamaoka [Japon] ; Shutoku Matsuyama [Japon] ; Shuetsu Fukushi [Japon] ; Satoko Matsunaga [Japon] ; Yuki Matsushima [Japon] ; Hiroyuki Kuroyama [Japon] ; Hirokazu Kimura [Japon] ; Makoto Takeda [Japon] ; Tomoyuki Chimuro [Japon] ; Akihide Ryo [Japon]Source :
- Frontiers in microbiology [ 1664-302X ] ; 2016.
Abstract
Protein nativity is one of the most critical factors for the quality of antigens used as immunogens and the reactivities of the resultant antibodies. The preparation and purification of native viral antigens in conventional cell-based protein expression systems are often accompanied by technical hardships. These challenges are attributable mainly to protein aggregation and insolubility during expression and purification, as well as to very low expression levels associated with the toxicity of some viral proteins. Here, we describe a novel approach for the production of monoclonal antibodies (mAbs) against nucleocapsid protein (NP) of the Middle East respiratory syndrome coronavirus (MERS-CoV). Using a wheat germ cell-free protein synthesis system, we successfully prepared large amounts of MERS-CoV NP antigen in a state that was highly soluble and intact for immunization. Following mouse immunization and hybridoma generation, we selected seven hybridoma clones that produced mAbs with exclusive reactivity against MERS-CoV NP. Epitope mapping and subsequent bioinformatic analysis revealed that these mAbs recognized epitopes located within relatively highly conserved regions of the MERS-CoV amino-acid sequence. Consistently, the mAbs exhibited no obvious cross-reactivity with NPs derived from other related viruses, including SARS coronavirus. After determining the optimal combinations of these mAbs, we developed an enzyme-linked immunosorbent assay and a rapid immunochromatographic antigen detection test that can be reliably used for laboratory diagnosis of MERS-CoV. Thus, this study provides strong evidence that the wheat germ cell-free system is useful for the production of diagnostic mAbs against emerging pathogens.
DOI: 10.3389/fmicb.2016.00509
PubMed: 27148198
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:27148198Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Development of Monoclonal Antibody and Diagnostic Test for Middle East Respiratory Syndrome Coronavirus Using Cell-Free Synthesized Nucleocapsid Antigen.</title><author><name sortKey="Yamaoka, Yutaro" sort="Yamaoka, Yutaro" uniqKey="Yamaoka Y" first="Yutaro" last="Yamaoka">Yutaro Yamaoka</name><affiliation wicri:level="1"><nlm:affiliation>Department of Microbiology, School of Medicine, Yokohama City UniversityYokohama, Japan; Isehara Research Laboratory, Technology and Development Division, Kanto Chemical Co., Inc.Isehara, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Microbiology, School of Medicine, Yokohama City UniversityYokohama, Japan; Isehara Research Laboratory, Technology and Development Division, Kanto Chemical Co., Inc.Isehara</wicri:regionArea><wicri:noRegion>Inc.Isehara</wicri:noRegion></affiliation></author><author><name sortKey="Matsuyama, Shutoku" sort="Matsuyama, Shutoku" uniqKey="Matsuyama S" first="Shutoku" last="Matsuyama">Shutoku Matsuyama</name><affiliation wicri:level="1"><nlm:affiliation>Department of Virology III, National Institute of Infectious Diseases Musashimurayama, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Virology III, National Institute of Infectious Diseases Musashimurayama</wicri:regionArea><wicri:noRegion>National Institute of Infectious Diseases Musashimurayama</wicri:noRegion></affiliation></author><author><name sortKey="Fukushi, Shuetsu" sort="Fukushi, Shuetsu" uniqKey="Fukushi S" first="Shuetsu" last="Fukushi">Shuetsu Fukushi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Virology I, National Institute of Infectious Diseases Musashimurayama, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Virology I, National Institute of Infectious Diseases Musashimurayama</wicri:regionArea><wicri:noRegion>National Institute of Infectious Diseases Musashimurayama</wicri:noRegion></affiliation></author><author><name sortKey="Matsunaga, Satoko" sort="Matsunaga, Satoko" uniqKey="Matsunaga S" first="Satoko" last="Matsunaga">Satoko Matsunaga</name><affiliation wicri:level="1"><nlm:affiliation>Department of Microbiology, School of Medicine, Yokohama City University Yokohama, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Microbiology, School of Medicine, Yokohama City University Yokohama</wicri:regionArea><wicri:noRegion>Yokohama City University Yokohama</wicri:noRegion></affiliation></author><author><name sortKey="Matsushima, Yuki" sort="Matsushima, Yuki" uniqKey="Matsushima Y" first="Yuki" last="Matsushima">Yuki Matsushima</name><affiliation wicri:level="1"><nlm:affiliation>Department of Microbiology, School of Medicine, Yokohama City UniversityYokohama, Japan; Division of Virology, Kawasaki City Institute for Public HealthKawasaki, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Microbiology, School of Medicine, Yokohama City UniversityYokohama, Japan; Division of Virology, Kawasaki City Institute for Public HealthKawasaki</wicri:regionArea><wicri:noRegion>Kawasaki City Institute for Public HealthKawasaki</wicri:noRegion></affiliation></author><author><name sortKey="Kuroyama, Hiroyuki" sort="Kuroyama, Hiroyuki" uniqKey="Kuroyama H" first="Hiroyuki" last="Kuroyama">Hiroyuki Kuroyama</name><affiliation wicri:level="1"><nlm:affiliation>Isehara Research Laboratory, Technology and Development Division, Kanto Chemical Co., Inc. Isehara, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Isehara Research Laboratory, Technology and Development Division, Kanto Chemical Co., Inc. Isehara</wicri:regionArea><wicri:noRegion>Inc. Isehara</wicri:noRegion></affiliation></author><author><name sortKey="Kimura, Hirokazu" sort="Kimura, Hirokazu" uniqKey="Kimura H" first="Hirokazu" last="Kimura">Hirokazu Kimura</name><affiliation wicri:level="1"><nlm:affiliation>Infectious Disease Surveillance Center, National Institute of Infectious Diseases Musashimurayama, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Infectious Disease Surveillance Center, National Institute of Infectious Diseases Musashimurayama</wicri:regionArea><wicri:noRegion>National Institute of Infectious Diseases Musashimurayama</wicri:noRegion></affiliation></author><author><name sortKey="Takeda, Makoto" sort="Takeda, Makoto" uniqKey="Takeda M" first="Makoto" last="Takeda">Makoto Takeda</name><affiliation wicri:level="1"><nlm:affiliation>Department of Virology III, National Institute of Infectious Diseases Musashimurayama, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Virology III, National Institute of Infectious Diseases Musashimurayama</wicri:regionArea><wicri:noRegion>National Institute of Infectious Diseases Musashimurayama</wicri:noRegion></affiliation></author><author><name sortKey="Chimuro, Tomoyuki" sort="Chimuro, Tomoyuki" uniqKey="Chimuro T" first="Tomoyuki" last="Chimuro">Tomoyuki Chimuro</name><affiliation wicri:level="1"><nlm:affiliation>Isehara Research Laboratory, Technology and Development Division, Kanto Chemical Co., Inc. Isehara, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Isehara Research Laboratory, Technology and Development Division, Kanto Chemical Co., Inc. Isehara</wicri:regionArea><wicri:noRegion>Inc. Isehara</wicri:noRegion></affiliation></author><author><name sortKey="Ryo, Akihide" sort="Ryo, Akihide" uniqKey="Ryo A" first="Akihide" last="Ryo">Akihide Ryo</name><affiliation wicri:level="1"><nlm:affiliation>Department of Microbiology, School of Medicine, Yokohama City University Yokohama, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Microbiology, School of Medicine, Yokohama City University Yokohama</wicri:regionArea><wicri:noRegion>Yokohama City University Yokohama</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:27148198</idno><idno type="pmid">27148198</idno><idno type="doi">10.3389/fmicb.2016.00509</idno><idno type="wicri:Area/PubMed/Corpus">000C57</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000C57</idno><idno type="wicri:Area/PubMed/Curation">000C57</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000C57</idno><idno type="wicri:Area/PubMed/Checkpoint">000C70</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000C70</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Development of Monoclonal Antibody and Diagnostic Test for Middle East Respiratory Syndrome Coronavirus Using Cell-Free Synthesized Nucleocapsid Antigen.</title><author><name sortKey="Yamaoka, Yutaro" sort="Yamaoka, Yutaro" uniqKey="Yamaoka Y" first="Yutaro" last="Yamaoka">Yutaro Yamaoka</name><affiliation wicri:level="1"><nlm:affiliation>Department of Microbiology, School of Medicine, Yokohama City UniversityYokohama, Japan; Isehara Research Laboratory, Technology and Development Division, Kanto Chemical Co., Inc.Isehara, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Microbiology, School of Medicine, Yokohama City UniversityYokohama, Japan; Isehara Research Laboratory, Technology and Development Division, Kanto Chemical Co., Inc.Isehara</wicri:regionArea><wicri:noRegion>Inc.Isehara</wicri:noRegion></affiliation></author><author><name sortKey="Matsuyama, Shutoku" sort="Matsuyama, Shutoku" uniqKey="Matsuyama S" first="Shutoku" last="Matsuyama">Shutoku Matsuyama</name><affiliation wicri:level="1"><nlm:affiliation>Department of Virology III, National Institute of Infectious Diseases Musashimurayama, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Virology III, National Institute of Infectious Diseases Musashimurayama</wicri:regionArea><wicri:noRegion>National Institute of Infectious Diseases Musashimurayama</wicri:noRegion></affiliation></author><author><name sortKey="Fukushi, Shuetsu" sort="Fukushi, Shuetsu" uniqKey="Fukushi S" first="Shuetsu" last="Fukushi">Shuetsu Fukushi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Virology I, National Institute of Infectious Diseases Musashimurayama, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Virology I, National Institute of Infectious Diseases Musashimurayama</wicri:regionArea><wicri:noRegion>National Institute of Infectious Diseases Musashimurayama</wicri:noRegion></affiliation></author><author><name sortKey="Matsunaga, Satoko" sort="Matsunaga, Satoko" uniqKey="Matsunaga S" first="Satoko" last="Matsunaga">Satoko Matsunaga</name><affiliation wicri:level="1"><nlm:affiliation>Department of Microbiology, School of Medicine, Yokohama City University Yokohama, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Microbiology, School of Medicine, Yokohama City University Yokohama</wicri:regionArea><wicri:noRegion>Yokohama City University Yokohama</wicri:noRegion></affiliation></author><author><name sortKey="Matsushima, Yuki" sort="Matsushima, Yuki" uniqKey="Matsushima Y" first="Yuki" last="Matsushima">Yuki Matsushima</name><affiliation wicri:level="1"><nlm:affiliation>Department of Microbiology, School of Medicine, Yokohama City UniversityYokohama, Japan; Division of Virology, Kawasaki City Institute for Public HealthKawasaki, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Microbiology, School of Medicine, Yokohama City UniversityYokohama, Japan; Division of Virology, Kawasaki City Institute for Public HealthKawasaki</wicri:regionArea><wicri:noRegion>Kawasaki City Institute for Public HealthKawasaki</wicri:noRegion></affiliation></author><author><name sortKey="Kuroyama, Hiroyuki" sort="Kuroyama, Hiroyuki" uniqKey="Kuroyama H" first="Hiroyuki" last="Kuroyama">Hiroyuki Kuroyama</name><affiliation wicri:level="1"><nlm:affiliation>Isehara Research Laboratory, Technology and Development Division, Kanto Chemical Co., Inc. Isehara, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Isehara Research Laboratory, Technology and Development Division, Kanto Chemical Co., Inc. Isehara</wicri:regionArea><wicri:noRegion>Inc. Isehara</wicri:noRegion></affiliation></author><author><name sortKey="Kimura, Hirokazu" sort="Kimura, Hirokazu" uniqKey="Kimura H" first="Hirokazu" last="Kimura">Hirokazu Kimura</name><affiliation wicri:level="1"><nlm:affiliation>Infectious Disease Surveillance Center, National Institute of Infectious Diseases Musashimurayama, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Infectious Disease Surveillance Center, National Institute of Infectious Diseases Musashimurayama</wicri:regionArea><wicri:noRegion>National Institute of Infectious Diseases Musashimurayama</wicri:noRegion></affiliation></author><author><name sortKey="Takeda, Makoto" sort="Takeda, Makoto" uniqKey="Takeda M" first="Makoto" last="Takeda">Makoto Takeda</name><affiliation wicri:level="1"><nlm:affiliation>Department of Virology III, National Institute of Infectious Diseases Musashimurayama, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Virology III, National Institute of Infectious Diseases Musashimurayama</wicri:regionArea><wicri:noRegion>National Institute of Infectious Diseases Musashimurayama</wicri:noRegion></affiliation></author><author><name sortKey="Chimuro, Tomoyuki" sort="Chimuro, Tomoyuki" uniqKey="Chimuro T" first="Tomoyuki" last="Chimuro">Tomoyuki Chimuro</name><affiliation wicri:level="1"><nlm:affiliation>Isehara Research Laboratory, Technology and Development Division, Kanto Chemical Co., Inc. Isehara, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Isehara Research Laboratory, Technology and Development Division, Kanto Chemical Co., Inc. Isehara</wicri:regionArea><wicri:noRegion>Inc. Isehara</wicri:noRegion></affiliation></author><author><name sortKey="Ryo, Akihide" sort="Ryo, Akihide" uniqKey="Ryo A" first="Akihide" last="Ryo">Akihide Ryo</name><affiliation wicri:level="1"><nlm:affiliation>Department of Microbiology, School of Medicine, Yokohama City University Yokohama, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Microbiology, School of Medicine, Yokohama City University Yokohama</wicri:regionArea><wicri:noRegion>Yokohama City University Yokohama</wicri:noRegion></affiliation></author></analytic><series><title level="j">Frontiers in microbiology</title><idno type="ISSN">1664-302X</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Protein nativity is one of the most critical factors for the quality of antigens used as immunogens and the reactivities of the resultant antibodies. The preparation and purification of native viral antigens in conventional cell-based protein expression systems are often accompanied by technical hardships. These challenges are attributable mainly to protein aggregation and insolubility during expression and purification, as well as to very low expression levels associated with the toxicity of some viral proteins. Here, we describe a novel approach for the production of monoclonal antibodies (mAbs) against nucleocapsid protein (NP) of the Middle East respiratory syndrome coronavirus (MERS-CoV). Using a wheat germ cell-free protein synthesis system, we successfully prepared large amounts of MERS-CoV NP antigen in a state that was highly soluble and intact for immunization. Following mouse immunization and hybridoma generation, we selected seven hybridoma clones that produced mAbs with exclusive reactivity against MERS-CoV NP. Epitope mapping and subsequent bioinformatic analysis revealed that these mAbs recognized epitopes located within relatively highly conserved regions of the MERS-CoV amino-acid sequence. Consistently, the mAbs exhibited no obvious cross-reactivity with NPs derived from other related viruses, including SARS coronavirus. After determining the optimal combinations of these mAbs, we developed an enzyme-linked immunosorbent assay and a rapid immunochromatographic antigen detection test that can be reliably used for laboratory diagnosis of MERS-CoV. Thus, this study provides strong evidence that the wheat germ cell-free system is useful for the production of diagnostic mAbs against emerging pathogens. </div></front></TEI><pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">27148198</PMID><DateCompleted><Year>2016</Year><Month>05</Month><Day>05</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-302X</ISSN><JournalIssue CitedMedium="Print"><Volume>7</Volume><PubDate><Year>2016</Year></PubDate></JournalIssue><Title>Frontiers in microbiology</Title><ISOAbbreviation>Front Microbiol</ISOAbbreviation></Journal><ArticleTitle>Development of Monoclonal Antibody and Diagnostic Test for Middle East Respiratory Syndrome Coronavirus Using Cell-Free Synthesized Nucleocapsid Antigen.</ArticleTitle><Pagination><MedlinePgn>509</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmicb.2016.00509</ELocationID><Abstract><AbstractText>Protein nativity is one of the most critical factors for the quality of antigens used as immunogens and the reactivities of the resultant antibodies. The preparation and purification of native viral antigens in conventional cell-based protein expression systems are often accompanied by technical hardships. These challenges are attributable mainly to protein aggregation and insolubility during expression and purification, as well as to very low expression levels associated with the toxicity of some viral proteins. Here, we describe a novel approach for the production of monoclonal antibodies (mAbs) against nucleocapsid protein (NP) of the Middle East respiratory syndrome coronavirus (MERS-CoV). Using a wheat germ cell-free protein synthesis system, we successfully prepared large amounts of MERS-CoV NP antigen in a state that was highly soluble and intact for immunization. Following mouse immunization and hybridoma generation, we selected seven hybridoma clones that produced mAbs with exclusive reactivity against MERS-CoV NP. Epitope mapping and subsequent bioinformatic analysis revealed that these mAbs recognized epitopes located within relatively highly conserved regions of the MERS-CoV amino-acid sequence. Consistently, the mAbs exhibited no obvious cross-reactivity with NPs derived from other related viruses, including SARS coronavirus. After determining the optimal combinations of these mAbs, we developed an enzyme-linked immunosorbent assay and a rapid immunochromatographic antigen detection test that can be reliably used for laboratory diagnosis of MERS-CoV. Thus, this study provides strong evidence that the wheat germ cell-free system is useful for the production of diagnostic mAbs against emerging pathogens. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yamaoka</LastName><ForeName>Yutaro</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Microbiology, School of Medicine, Yokohama City UniversityYokohama, Japan; Isehara Research Laboratory, Technology and Development Division, Kanto Chemical Co., Inc.Isehara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsuyama</LastName><ForeName>Shutoku</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Virology III, National Institute of Infectious Diseases Musashimurayama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fukushi</LastName><ForeName>Shuetsu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Virology I, National Institute of Infectious Diseases Musashimurayama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsunaga</LastName><ForeName>Satoko</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Microbiology, School of Medicine, Yokohama City University Yokohama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsushima</LastName><ForeName>Yuki</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Microbiology, School of Medicine, Yokohama City UniversityYokohama, Japan; Division of Virology, Kawasaki City Institute for Public HealthKawasaki, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuroyama</LastName><ForeName>Hiroyuki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Isehara Research Laboratory, Technology and Development Division, Kanto Chemical Co., Inc. Isehara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kimura</LastName><ForeName>Hirokazu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Infectious Disease Surveillance Center, National Institute of Infectious Diseases Musashimurayama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takeda</LastName><ForeName>Makoto</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Virology III, National Institute of Infectious Diseases Musashimurayama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chimuro</LastName><ForeName>Tomoyuki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Isehara Research Laboratory, Technology and Development Division, Kanto Chemical Co., Inc. Isehara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryo</LastName><ForeName>Akihide</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Microbiology, School of Medicine, Yokohama City University Yokohama, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>04</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Microbiol</MedlineTA><NlmUniqueID>101548977</NlmUniqueID><ISSNLinking>1664-302X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">MERS-coronavirus</Keyword><Keyword MajorTopicYN="N">antigen</Keyword><Keyword MajorTopicYN="N">cell-free protein synthesis</Keyword><Keyword MajorTopicYN="N">detection</Keyword><Keyword MajorTopicYN="N">diagnosis</Keyword><Keyword MajorTopicYN="N">monoclonal antibody</Keyword><Keyword MajorTopicYN="N">nucleocapsid</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>02</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>03</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27148198</ArticleId><ArticleId IdType="doi">10.3389/fmicb.2016.00509</ArticleId><ArticleId IdType="pmc">PMC4837155</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Viruses. 2014 Aug 07;6(8):2991-3018</Citation><ArticleIdList><ArticleId IdType="pubmed">25105276</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2012 Sep 27;17(39):null</Citation><ArticleIdList><ArticleId IdType="pubmed">23041020</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol Methods. 2005 Jul;127(1):46-53</Citation><ArticleIdList><ArticleId IdType="pubmed">15893565</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2013 Nov;87(21):11950-4</Citation><ArticleIdList><ArticleId IdType="pubmed">23986586</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Microbiol. 2004 Jul;42(7):2884-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15243033</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2012 Nov 8;367 (19):1814-20</Citation><ArticleIdList><ArticleId IdType="pubmed">23075143</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Biotechnol. 2006 Aug;17(4):373-80</Citation><ArticleIdList><ArticleId IdType="pubmed">16828277</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Biotechnol. 1991 Oct;2(5):746-50</Citation><ArticleIdList><ArticleId IdType="pubmed">1367729</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Microbiol. 2014 May 13;5:208</Citation><ArticleIdList><ArticleId IdType="pubmed">24860558</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Transl Med. 2014 Apr 30;6(234):234ra59</Citation><ArticleIdList><ArticleId IdType="pubmed">24778414</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Microbes Infect. 2015 Dec 02;4(12 ):e74</Citation><ArticleIdList><ArticleId IdType="pubmed">26632876</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2013 Dec;87(23):12552-61</Citation><ArticleIdList><ArticleId IdType="pubmed">24027332</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Diagn Lab Immunol. 2005 Jul;12(7):848-54</Citation><ArticleIdList><ArticleId IdType="pubmed">16002634</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2014 May 13;111(19):E2018-26</Citation><ArticleIdList><ArticleId IdType="pubmed">24778221</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Biol Evol. 2011 Oct;28(10):2731-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21546353</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol Methods. 2013 Feb;187(2):413-20</Citation><ArticleIdList><ArticleId IdType="pubmed">23174159</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Microbiol. 2013 Nov 26;4:346</Citation><ArticleIdList><ArticleId IdType="pubmed">24324462</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Microbiol. 2015 Apr;53(4):1178-82</Citation><ArticleIdList><ArticleId IdType="pubmed">25631809</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 1994 Oct 7;269(40):24523-6</Citation><ArticleIdList><ArticleId IdType="pubmed">7929118</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2012 Dec 06;17(49):null</Citation><ArticleIdList><ArticleId IdType="pubmed">23231891</ArticleId></ArticleIdList></Reference><Reference><Citation>Paediatr Respir Rev. 2015 Jun;16(3):197-202</Citation><ArticleIdList><ArticleId IdType="pubmed">26002405</ArticleId></ArticleIdList></Reference><Reference><Citation>ILAR J. 2005;46(3):269-79</Citation><ArticleIdList><ArticleId IdType="pubmed">15953834</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Pharm Biotechnol. 2010 Apr;11(3):272-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20210744</ArticleId></ArticleIdList></Reference><Reference><Citation>ILAR J. 2005;46(3):280-93</Citation><ArticleIdList><ArticleId IdType="pubmed">15953835</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Microbiol. 2015 Oct 31;6:1220</Citation><ArticleIdList><ArticleId IdType="pubmed">26583013</ArticleId></ArticleIdList></Reference><Reference><Citation>J Comput Chem. 2004 Oct;25(13):1605-12</Citation><ArticleIdList><ArticleId IdType="pubmed">15264254</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochemistry. 2004 May 25;43(20):6059-63</Citation><ArticleIdList><ArticleId IdType="pubmed">15147189</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2014 Dec 1;59(11):1511-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25100864</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Mol Biol. 2010;607:23-30</Citation><ArticleIdList><ArticleId IdType="pubmed">20204845</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2004 Mar 19;32(5):1792-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15034147</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2009 Oct 08;4(10):e7388</Citation><ArticleIdList><ArticleId IdType="pubmed">19812689</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 1996 Aug 30;271(35):21439-45</Citation><ArticleIdList><ArticleId IdType="pubmed">8702926</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2016 Feb 15;62(4):477-83</Citation><ArticleIdList><ArticleId IdType="pubmed">26565003</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2013 Sep;13(9):745-51</Citation><ArticleIdList><ArticleId IdType="pubmed">23782859</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Mol Biol. 2005;310:145-67</Citation><ArticleIdList><ArticleId IdType="pubmed">16350953</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Microbes Infect. 2015 Apr;4(4):e26</Citation><ArticleIdList><ArticleId IdType="pubmed">26421268</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Rev Vaccines. 2014 Jun;13(6):761-74</Citation><ArticleIdList><ArticleId IdType="pubmed">24766432</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol Methods. 2006 Nov;137(2):343-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16904198</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Lab Anal. 2005;19(4):150-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16025480</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Res. 2015 Nov;25(11):1237-49</Citation><ArticleIdList><ArticleId IdType="pubmed">26391698</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2013 Mar 14;495(7440):251-4</Citation><ArticleIdList><ArticleId IdType="pubmed">23486063</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncotarget. 2015 Sep 8;6(26):21840-52</Citation><ArticleIdList><ArticleId IdType="pubmed">26334101</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol Methods. 2006 Oct;137(1):82-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16849028</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2013 Jul;87(14):7790-2</Citation><ArticleIdList><ArticleId IdType="pubmed">23678167</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncotarget. 2014 Sep 30;5(18):8665-80</Citation><ArticleIdList><ArticleId IdType="pubmed">25228591</ArticleId></ArticleIdList></Reference><Reference><Citation>Electrophoresis. 1997 Dec;18(15):2714-23</Citation><ArticleIdList><ArticleId IdType="pubmed">9504803</ArticleId></ArticleIdList></Reference><Reference><Citation>Proteins. 2012 Jul;80(7):1715-35</Citation><ArticleIdList><ArticleId IdType="pubmed">22411565</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4303-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17360519</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2015 Jan;12(1):7-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25549265</ArticleId></ArticleIdList></Reference><Reference><Citation>J Mol Biol. 2007 May 11;368(4):1075-86</Citation><ArticleIdList><ArticleId IdType="pubmed">17379242</ArticleId></ArticleIdList></Reference><Reference><Citation>MBio. 2012 Nov 20;3(6):null</Citation><ArticleIdList><ArticleId IdType="pubmed">23170002</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Mol Biol. 2014;1137:1-15</Citation><ArticleIdList><ArticleId IdType="pubmed">24573470</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2008 Dec;5(12):1011-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19054851</ArticleId></ArticleIdList></Reference><Reference><Citation>Virol J. 2014 Aug 08;11:139</Citation><ArticleIdList><ArticleId IdType="pubmed">25103205</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2015 Jun 10;5:11333</Citation><ArticleIdList><ArticleId IdType="pubmed">26061673</ArticleId></ArticleIdList></Reference><Reference><Citation>Antiviral Res. 2014 Mar;103:39-50</Citation><ArticleIdList><ArticleId IdType="pubmed">24418573</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Japon</li></country></list><tree><country name="Japon"><noRegion><name sortKey="Yamaoka, Yutaro" sort="Yamaoka, Yutaro" uniqKey="Yamaoka Y" first="Yutaro" last="Yamaoka">Yutaro Yamaoka</name></noRegion><name sortKey="Chimuro, Tomoyuki" sort="Chimuro, Tomoyuki" uniqKey="Chimuro T" first="Tomoyuki" last="Chimuro">Tomoyuki Chimuro</name><name sortKey="Fukushi, Shuetsu" sort="Fukushi, Shuetsu" uniqKey="Fukushi S" first="Shuetsu" last="Fukushi">Shuetsu Fukushi</name><name sortKey="Kimura, Hirokazu" sort="Kimura, Hirokazu" uniqKey="Kimura H" first="Hirokazu" last="Kimura">Hirokazu Kimura</name><name sortKey="Kuroyama, Hiroyuki" sort="Kuroyama, Hiroyuki" uniqKey="Kuroyama H" first="Hiroyuki" last="Kuroyama">Hiroyuki Kuroyama</name><name sortKey="Matsunaga, Satoko" sort="Matsunaga, Satoko" uniqKey="Matsunaga S" first="Satoko" last="Matsunaga">Satoko Matsunaga</name><name sortKey="Matsushima, Yuki" sort="Matsushima, Yuki" uniqKey="Matsushima Y" first="Yuki" last="Matsushima">Yuki Matsushima</name><name sortKey="Matsuyama, Shutoku" sort="Matsuyama, Shutoku" uniqKey="Matsuyama S" first="Shutoku" last="Matsuyama">Shutoku Matsuyama</name><name sortKey="Ryo, Akihide" sort="Ryo, Akihide" uniqKey="Ryo A" first="Akihide" last="Ryo">Akihide Ryo</name><name sortKey="Takeda, Makoto" sort="Takeda, Makoto" uniqKey="Takeda M" first="Makoto" last="Takeda">Makoto Takeda</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C70 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000C70 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:27148198
|texte= Development of Monoclonal Antibody and Diagnostic Test for Middle East Respiratory Syndrome Coronavirus Using Cell-Free Synthesized Nucleocapsid Antigen.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:27148198" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |